Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

MAIA Biotechnology, Inc. (MAIA)

1.61   0.15 (10.27%) 09-27 16:00
Open: 1.5 Pre. Close: 1.46
High: 1.64 Low: 1.5
Volume: 74,279 Market Cap: 22(M)

Technical analysis

as of: 2023-09-27 4:20:39 PM
Short-term rate:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Mid-term rate:       
Target: Six months: 2.18     One year: 2.51
Support: Support1: 1.41    Support2: 1.18
Resistance: Resistance1: 1.87    Resistance2: 2.15
Pivot: 1.62
Moving Average: MA(5): 1.51     MA(20): 1.67
MA(100): 2.13     MA(250): 3.06
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 17.7     %D(3): 14.9
RSI: RSI(14): 43.6
52-week: High: 5.21  Low: 1.41
Average Vol(K): 3-Month: 30 (K)  10-Days: 35 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MAIA ] has closed above bottom band by 47.3%. Bollinger Bands are 17.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.64 - 1.65 1.65 - 1.66
Low: 1.48 - 1.49 1.49 - 1.5
Close: 1.6 - 1.61 1.61 - 1.62

Company Description

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Headline News

Tue, 08 Aug 2023
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer - Yahoo Finance

Mon, 10 Jul 2023
MAIA Biotechnology Reports Updates on Preliminary Survival Data ... - Business Wire

Tue, 20 Jun 2023
MAIA Biotechnology Announces Updates in Enrollment in Phase II ... - Business Wire

Wed, 07 Jun 2023
MAIA Biotechnology Files Second Patent For New Telomere ... - Business Wire

Thu, 27 Apr 2023
MAIA Biotechnology, Inc. Announces Closing of Public Offering - Business Wire

Mon, 24 Apr 2023
MAIA Biotechnology, Inc. Announces Pricing of Public Offering - Business Wire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 0 (%)
% Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.